Chris Mulroney Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3181 since 2023-09-25 the company is, as the updated on 2023-09-25 ABN database shows, registered. Known company numbers for Chris Mulroney Pty Ltd are as follows: ACN - 009305882, Australian Business Number - 95009305882. Medipoint On Malvern is an example of a business name Chris Mulroney Pty Ltd used. The complete list includes 2 business names. Medipoint On Malvern was the company's business name from 2013-09-30 until 2017-02-09. Other business names include Medipoint (from 2000-05-10 to 2002-01-18). Their official company name changed on 2000-05-10 to Christopher Mulroney Pty Ltd. The company had used this name up until 2000-08-04. This Australian proprietary company was previously located in WA 6021 (from 2014-09-12 to 2023-09-25), WA 6021 (from 2010-04-04 to 2014-09-12), WA 6021 (from 2000-05-10 to 2010-04-04).
Status | From | To |
---|---|---|
Active | 2000/05/10 | current |
Name | From | To |
---|---|---|
Chris Mulroney Pty Ltd | 2000/08/04 | current |
Christopher Mulroney Pty Ltd | 2000/05/10 | 2000/08/04 |
Name | From | To |
---|---|---|
Medipoint On Malvern | 2013/09/30 | 2017/02/09 |
Medipoint | 2000/05/10 | 2002/01/18 |
Location | From | To |
---|---|---|
VIC 3181 | 2023/09/25 | current |
WA 6021 | 2014/09/12 | 2023/09/25 |
WA 6021 | 2010/04/04 | 2014/09/12 |
WA 6021 | 2000/05/10 | 2010/04/04 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.